The pursuit of global health: The relevance of engagement for developed countries

Lancet

Volumn 351, Issue 9102, 1998, Pages 586-590

  Howson, Christopher P ^a   Fineberg, Harvey V ^b   Bloom, Barry R ^c  

^a NATIONAL ACADEMY OF SCIENCES   (United States)

^b HARVARD UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMMERCIAL PHENOMENA; DEVELOPED COUNTRY; FOOD CONTAMINATION; HUMAN; INFECTION; INTERNATIONAL COOPERATION; INTERPERSONAL COMMUNICATION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; TRAVEL; VIOLENCE;

EID: 0032554267     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)11452-0     Document Type: Review

References (8)

1. 1 Garrett L. The return of infectious disease. Foreign Affairs 1996; January/February: 66-79.
2. 2 World Bank. World development report 1993: investing in health. New York: Oxford University Press, 1993.
3. 3 Committee on International Science, Engineering, and Technology. Global microbial threats in the 1990s: report of the NSTC Committee on International Science, Engineering, and Technology (CISET) working group on emerging and re-emerging infectious diseases. Washington DC: National Science and Technology Council.
4. 4 Linden E. The exploding cities of the developing world. Foreign Affairs 1996; January/February: 52-65.
5. 5 Kaplan DE, Marshall A. The cult at the end of the world. New York: Crown, 1996.
6. 6 Ballance R, Pogany J, Forstner H. The world's pharmaceutical industries: an international perspective on innovation, competition and policy. Prepared for UN Industrial Development Organization (UNIDO). UK: Edward Elgar, 1992.
7. 7 Institute of Medicine. Pharmaceutical innovation and the needs of developing countries. Washington DC: National Academy Press, 1979.
8. 8 UN Development Program. Human development report. New York: Oxford University Press, 1991.